KU 210 (Montelukast sodium 10 mg (base))

Pill imprint KU 210 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of bronchospasm prophylaxis; asthma, maintenance; hay fever; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for KU 210

Montelukast sodium 10 mg (base) KU 210
Montelukast sodium
Imprint:
KU
210
Strength:
10 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Kremers Urban Pharmaceuticals Inc.
National Drug Code (NDC):
62175-0210
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hydroxypropyl cellulose (type h)
mannitol
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
sodium stearyl fumarate
magnesium silicate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)